Johnson & Johnson drew sharp criticism two weeks ago amid reports that doses of its single-shot COVID-19 vaccine produced in South Africa were being exported to Europe. Now, it appears that the arrangement is coming to an end.
J&J doses manufactured at Aspen Pharmacare’s facility in South Africa will now be shipped to African countries, the Wall Street Journal reports, citing comments from African Union’s Strive Masiyiwa. In addition, millions of doses that had been shipped to Europe and stored in warehouses will be returned to the continent.